Jan
10
2026

How Clinical Research Networks are transforming rare disease research | CRNs conference highlights

The 2nd International Conference on Clinical Research Networks (CRNs) showcased the vital role of CRNs as structured collaborations that unite expert clinical sites, laboratories, patient organisations and other key stakeholders. In this video, hear directly from conference participants as they share insights on how Clinical Research Networks are accelerating prevention, diagnosis, observational studies and clinical trials for rare and groups of rare diseases. Discover how CRNs are helping to shape the future of rare disease research, innovation and patient care worldwide. The conference was organised by ERDERA, Rare Diseases International (RDI) and the International Rare Diseases Research Consortium (IRDiRC). Next edition: December 2027.

News & Updates

You might also be interested in

ERDERA joins the Wilhelm Foundation and the Gdansk Medical University and Clinical Centre to strengthen phenotype‑led diagnosis for people living with undiagnosed conditions
Taking place at a pivotal moment – with the European Rare Disease Plan expected to move forward significantly during 2026 – the meetings brought together National Mirror Group (NMG) representatives from Europe and beyond, alongside European Commission stakeholders, IRDiRC and international partners.
A legislative own initiative file in the Parliament’s new public health committee sets out what an EU “rare disease action framework” could look like — and why it could change how Europe measures progress for patients.
Drawing on Europe-wide patient and carer surveys, ERDERA highlights how gender can shape diagnostic delays, care burden and the evidence base for rare-disease research.